Publications by authors named "Bodo Brunner"

Claim this Profile
T
Trivalent siRNA-Conjugates with Guanosine as ASGPR-Binder Show Potent Knock-Down In Vivo.
Armin Hofmeister, Kerstin Jahn-Hofmann, Bodo Brunner, Mike Helms, Christiane Metz-Weidmann

J Med Chem· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small Interfering RNAs Containing Dioxane- and Morpholino-Derived Nucleotide Analogues Show Improved Off-Target Profiles and Chirality-Dependent Knock-Down.
Armin Hofmeister, Kerstin Jahn-Hofmann, Bodo Brunner, Mike Helms, Christiane Metz-Weidmann

J Med Chem· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver-Specific Knockdown of Class IIa HDACs Has Limited Efficacy on Glucose Metabolism but Entails Severe Organ Side Effects in Mice.
Nicole Ziegler, Suryaprakash Raichur, Bodo Brunner, Ulrike Hemmann, Manuela Stolte

Front Endocrinol (Lausanne)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Syntheses of Morpholine-Based Nucleotide Analogs for Hepatic siRNA Targeting and Stabilization.
Armin Hofmeister, Kerstin Jahn-Hofmann, Bodo Brunner, Mike W Helms, Christiane Metz-Weidmann

J Med Chem· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanobody-siRNA Conjugates for Targeted Delivery of siRNA to Cancer Cells.
Oleksandr Zavoiura, Bodo Brunner, Peter Casteels, Luciana Zimmermann, Matthias Ozog

Mol Pharm· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of the RIG-I Agonist Triphosphate RNA for Melanoma Therapy.
Mike W Helms, Kerstin Jahn-Hofmann, Felix Gnerlich, Christiane Metz-Weidmann, Monika Braun, Bodo Brunner

Mol Cancer Ther· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach.
Suryaprakash Raichur, Bodo Brunner, Maximilian Bielohuby, Gitte Hansen, Anja Pfenninger

Mol Metab· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Activation of Hepatic Nrf2 Has No Major Effect on Fatty Acid and Glucose Metabolism in Adult Mice.
Sebastian Brachs, Angelika F Winkel, James Polack, Hui Tang, Maria Brachs, Bodo Brunner

PLoS One· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Chronic Activation of Hepatic Nrf2 Has No Major Effect on Fatty Acid and Glucose Metabolism in Adult Mice.
Sebastian Brachs, Angelika F Winkel, James Polack, Hui Tang, Maria Brachs, Bodo Brunner

PLoS One· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice.
Sebastian Brachs, Angelika F Winkel, Hui Tang, Andreas L Birkenfeld, Bodo Brunner

Mol Metab· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pau d'arco activates Nrf2-dependent gene expression via the MEK/ERK-pathway.
Michelle Richter, Angelika F Winkel, Dietmar Schummer, Martin Gerlitz, Meltsje de Hoop, Bodo Brunner

J Toxicol Sci· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy.
Holger Schmid, Anissa Boucherot, Yoshinari Yasuda, Anna Henger, Bodo Brunner

Diabetes· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative promoter analysis allows de novo identification of specialized cell junction-associated proteins.
Clemens D Cohen, Andreas Klingenhoff, Anissa Boucherot, Almut Nitsche, Anna Henger, Bodo Brunner

Proc Natl Acad Sci U S A· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligonucleotide-based knockdown technologies: antisense versus RNA interference.
Tatjana V Achenbach, Bodo Brunner, Kathrin Heermeier

Chembiochem· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis